Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Husam Younis currently holds 41,441 shares of Atrium Therapeutics, Inc. (RNA), valued at approximately $0. This represents their equity stake as Chief Scientific Officer.
Based on SEC Form 4 filings, Husam Younis has been a net neutral trader of RNA stock. They have purchased $0 and sold $0 worth of shares.
Husam Younis's most recent insider trade was on Sep 18, 2026, when they sold 11,216 shares at $8.95 per share.
Husam Younis serves as Chief Scientific Officer at Atrium Therapeutics, Inc. (RNA). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Husam Younis holds the position of Chief Scientific Officer at Atrium Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Husam Younis has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Husam Younis was on Sep 18, 2026, when they sold $100.4K worth of RNA shares. This transaction involved 11,216 shares at $8.95 per share.
Husam Younis currently owns 41,441 shares of Atrium Therapeutics, Inc. (RNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Husam Younis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Husam Younis has 3 Form 4 filings on record as an insider at Atrium Therapeutics, Inc..
Set alerts for Husam Younis and 40,000+ other insiders.